retatrutide vs mots c MOTS-C & at the same time (this one is awesome) Comment “HELP” for research Let me paint you a picture of what MOTS-C and Retatrutide actually are… The actual biological mechanisms Retatrutide, MOTS-C & Insulin resistance

fast 20262029 pipeline snapshot: Novo Nordisk CagriSema (GLP-1 + amylin) Filing 2026 Lilly Orforglipron (oral GLP-1) + Retatrutide (triple agonist) Launch window 20262027 Amgen Maritide (GLP-1 + GIP) 20272028 target BI / Zealand Survodutide (GLP-1 + glucagon) 2027 Altimmune Pemvidutide (GLP-1 + glucagon) 2027 Roche CT-388 / Petrelintide possible 2029 And one notable miss: Pfizer Danuglipron discontinued Clear trend: Single GLP-1 dual triple agonists Competition is shifting from: Who has a GLP-1? to Who has the most effective combination biology? Execution risk is still real but the bar for efficacy is moving quickly

Chen: "Have you heard of GLP-1 medications like Ozempic or Wegovy?" Monica: "Yes, Ive seen them on the news

People with 15-30 pounds to lose

Bergmann NC, Lund A, Gasbjerg LS, et al

All care is delivered by licensed medical professionals

Absolute Best Insurance can help you review your prescription coverage, compare Medicare plan options, and understand how new federal drug programs may affect your costs